Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant APOC3 anticorps

L’anticorps Lapin Monoclonal anti-APOC3 a été validé pour ELISA et IHC. Il convient pour détecter APOC3 dans des échantillons de Humain.
N° du produit ABIN7127343

Aperçu rapide pour Recombinant APOC3 anticorps (ABIN7127343)

Antigène

Voir toutes APOC3 Anticorps
APOC3 (Apolipoprotein C-III (APOC3))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 47
  • 36
  • 30
Humain

Hôte

  • 60
  • 10
  • 6
Lapin

Clonalité

  • 68
  • 8
Monoclonal

Conjugué

  • 32
  • 10
  • 8
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp APOC3 est non-conjugé

Application

  • 55
  • 28
  • 23
  • 14
  • 14
  • 14
  • 8
  • 7
  • 7
  • 5
  • 5
  • 3
  • 2
  • 2
  • 1
ELISA, Immunohistochemistry (IHC)

Clone

8H12
  •  Réactivité croisée

    Humain

    Purification

    Affinity-chromatography

    Immunogène

    A synthesized peptide derived from human APOC3

    Isotype

    IgG
  • Indications d'application

    Recommended dilution: IHC:1:50-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène

    APOC3 (Apolipoprotein C-III (APOC3))

    Autre désignation

    APOC3

    Sujet

    Background: Component of triglyceride-rich very low density lipoproteins (VLDL) and high density lipoproteins (HDL) in plasma (PubMed:18201179, PubMed:22510806). Plays a multifaceted role in triglyceride homeostasis (PubMed:18201179, PubMed:22510806). Intracellularly, promotes hepatic very low density lipoprotein 1 (VLDL1) assembly and secretion, extracellularly, attenuates hydrolysis and clearance of triglyceride-rich lipoproteins (TRLs) (PubMed:18201179, PubMed:22510806). Impairs the lipolysis of TRLs by inhibiting lipoprotein lipase and the hepatic uptake of TRLs by remnant receptors (PubMed:18201179, PubMed:22510806). Formed of several curved helices connected via semiflexible hinges, so that it can wrap tightly around the curved micelle surface and easily adapt to the different diameters of its natural binding partners (PubMed:18408013).

    Aliases: Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3), APOC3

    UniProt

    P02656

    Pathways

    Carbohydrate Homeostasis, Lipid Metabolism
Vous êtes ici:
Chat with us!